These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7877117

  • 1. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment--neurobiological and psychometric assessment of course.
    Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V.
    J Psychiatr Res; 1994; 28(4):381-99. PubMed ID: 7877117
    [Abstract] [Full Text] [Related]

  • 2. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 4. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 Oct; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 5. [Monitoring the neurobiological and psychopathological course in therapy of depression. Trimipramine, sleep deprivation and light].
    Holsboer-Trachsler E.
    Bibl Psychiatr; 1994 Oct; (166):1-138. PubMed ID: 7980382
    [No Abstract] [Full Text] [Related]

  • 6. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A.
    Depression; 1996 Oct; 4(1):1-13. PubMed ID: 9160649
    [Abstract] [Full Text] [Related]

  • 7. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I, Yassouridis A, Holsboer F.
    J Psychiatr Res; 1994 Oct; 28(4):341-56. PubMed ID: 7877114
    [Abstract] [Full Text] [Related]

  • 8. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
    Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 10. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 11. Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'.
    Krieg JC, Lauer CJ, Schreiber W, Modell S, Holsboer F.
    J Affect Disord; 2001 Jan; 62(1-2):33-7. PubMed ID: 11172871
    [Abstract] [Full Text] [Related]

  • 12. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 13. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 14. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 15. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 16. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F.
    Exp Clin Endocrinol Diabetes; 1996 May 15; 104(1):31-7. PubMed ID: 8750568
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    J Psychiatr Res; 2003 May 15; 37(2):135-43. PubMed ID: 12842167
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.